{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:46:28Z","timestamp":1777441588446,"version":"3.51.4"},"reference-count":20,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"abstract":"\n Context:<\/jats:title>\n Higher serum TSH levels, both within the reference range and in those with subclinical hypothyroidism (SCH), have been associated with increased risk of atherosclerosis and cardiovascular (CV) events in a number of cross-sectional and longitudinal studies.<\/jats:p>\n <\/jats:sec>\n \n Objective:<\/jats:title>\n Our objective was to evaluate blood thrombogenicity in patients post\u2013non-ST elevation acute coronary syndrome (NSTE-ACS) in relation to their thyroid function.<\/jats:p>\n <\/jats:sec>\n \n Design, Patients, and Outcome Measure:<\/jats:title>\n At 1 week after troponin-positive NSTE-ACS, 70 patients who had been treated with optimal antiplatelet and secondary prevention therapy were studied. Patients with known thyroid disease or on medications affecting thyroid function were excluded. Blood thrombogenicity was assessed using the ex vivo Badimon perfusion chamber.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Serum TSH was associated with higher thrombus burden (\u03b2 = .30; P = .01) independent of other well-established CV risk factors. Patients with SCH (n = 12; 17%) had a higher thrombus burden than euthyroid individuals as evidenced by the area of the thrombus: mean (SD) 23 608 (10 498) vs 16 661 (10 902) \u03bcm2\/mm (P = .02). However, this association was not evident when the analysis was limited to patients with serum TSH within the reference range. In addition, neither serum free T4 nor free T3 had any significant association with thrombus area.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Serum TSH levels, particularly in the SCH range, are associated with higher thrombus burden despite optimal recommended secondary prevention therapy after NSTE-ACS. This may explain the higher CV risk seen in SCH patients. Future trials to assess the effect of individualized antithrombotic as well as thyroid hormone replacement therapy to reduce atherothrombotic risk in this population are needed.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/jc.2013-3062","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T15:28:21Z","timestamp":1394810901000},"page":"E1050-E1054","source":"Crossref","is-referenced-by-count":20,"title":["Blood Thrombogenicity Is Independently Associated With Serum TSH Levels in Post\u2013Non-ST Elevation Acute Coronary Syndrome"],"prefix":"10.1210","volume":"99","author":[{"given":"Girish","family":"Viswanathan","sequence":"first","affiliation":[{"name":"Institutes of Cellular Medicine (G.V., K.B., S.M., A.Z.), Newcastle upon Tyne NE1 7RU, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Balasubramaniam","sequence":"additional","affiliation":[{"name":"Institutes of Cellular Medicine (G.V., K.B., S.M., A.Z.), Newcastle upon Tyne NE1 7RU, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hardy","sequence":"additional","affiliation":[{"name":"Gateshead Health National Health Service Foundation Trust (R.H., S.R.), Gateshead NE9 6SX, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Marshall","sequence":"additional","affiliation":[{"name":"Institutes of Cellular Medicine (G.V., K.B., S.M., A.Z.), Newcastle upon Tyne NE1 7RU, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azfar","family":"Zaman","sequence":"additional","affiliation":[{"name":"Institutes of Cellular Medicine (G.V., K.B., S.M., A.Z.), Newcastle upon Tyne NE1 7RU, United Kingdom;"},{"name":"Department of Cardiology (A.Z.), Freeman Hospital, Newcastle upon Tyne NE7 7DN, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Razvi","sequence":"additional","affiliation":[{"name":"Institute of Genetic Medicine (S.R.), Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom;"},{"name":"Gateshead Health National Health Service Foundation Trust (R.H., S.R.), Gateshead NE9 6SX, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613385574000_B1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"2020071613385574000_B2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/1741826711416045","article-title":"Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases","volume":"19","author":"Westerink","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"2020071613385574000_B3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archinte.167.14.1526","article-title":"Association between increased mortality and mild thyroid dysfunction in cardiac patients","volume":"167","author":"Iervasi","year":"2007","journal-title":"Arch Intern Med"},{"key":"2020071613385574000_B4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MAJ.0b013e31822846bd","article-title":"Persistence of mortality risk in patients with acute cardiac diseases and mild thyroid dysfunction","volume":"343","author":"Molinaro","year":"2012","journal-title":"Am J Med Sci"},{"key":"2020071613385574000_B5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"key":"2020071613385574000_B6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jacc.2007.02.028","article-title":"ACC\/AHA 2007 guidelines for the management of patients with unstable angina\/non-ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina\/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2020071613385574000_B7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"2020071613385574000_B8","first-page":"A17675","article-title":"Higher thrombus burden and impaired clot kinetics in patients with type 2 diabetes mellitus following non ST-elevation acute coronary syndrome","volume":"122","author":"Viswanathan","year":"2010","journal-title":"Circulation"},{"key":"2020071613385574000_B9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"2020071613385574000_B10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","article-title":"Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality","volume":"148","author":"Ochs","year":"2008","journal-title":"Ann Intern Med"},{"key":"2020071613385574000_B11","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1210\/jc.2008-0167","article-title":"The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis","volume":"93","author":"Razvi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613385574000_B12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2265.2012.04477.x","article-title":"Thyroid function and the risk of coronary heart disease: 12-year follow-up of the hunt study in norway","volume":"77","author":"Asvold","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613385574000_B13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2006-1869","article-title":"The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial","volume":"92","author":"Razvi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613385574000_B14","first-page":"273","article-title":"The effect of thyroid hormone therapy on angiographic coronary artery disease progression","volume":"13","author":"Perk","year":"1997","journal-title":"Can J Cardiol"},{"key":"2020071613385574000_B15","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","article-title":"Lipoprotein profile in subclinical hypothyroidism: Response to levothyroxine replacement, a randomized placebo-controlled study","volume":"87","author":"Caraccio","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613385574000_B16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archinternmed.2012.1159","article-title":"Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality","volume":"172","author":"Razvi","year":"2012","journal-title":"Arch Intern Med"},{"key":"2020071613385574000_B17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/thy.2012.0033","article-title":"The mean platelet volume is positively correlated with serum thyrotropin concentrations in a population of healthy subjects with unsuspected subclinical hypothyroidism","volume":"23","author":"Kim","year":"2013","journal-title":"Thyroid"},{"key":"2020071613385574000_B18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0735-1097(00)01181-5","article-title":"Administration of abciximab to patients receiving tirofiban or eptifibatide: Effect on platelet function","volume":"37","author":"Lev","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2020071613385574000_B19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1538-7836.2003.00201.x","article-title":"Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis","volume":"1","author":"Sarich","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2020071613385574000_B20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1160\/TH12-06-0408","article-title":"Thrombus and antiplatelet therapy in type 2 diabetes mellitus. A prospective study after non-st elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina","volume":"108","author":"Viswanathan","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/6\/E1050\/9045343\/jcem1050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/6\/E1050\/9045343\/jcem1050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:18:40Z","timestamp":1594945120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/6\/E1050\/2537316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-3062","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}